Learn About Retinal Vasculopathy with Cerebral Leukodystrophy
- Retinal vasculopathy with cerebral leukodystrophy with systemic manifestations
- Hereditary vascular retinopathy
- ADRVCL
- Autosomal Dominant Retinal Vasculopathy with Cerebral Leukodystrophy
- CRV
- Cerebroretinal vasculopathy, hereditary
- RVCL
- RVCL-S
- Retinal vasculopathy and cerebral leukoencephalopathy
- Retinopathy, vascular, with cerebral and renal involvement and Raynaud and migraine phenomena
- HVR
University Of North Carolina At Chapel Hill
Alessandro Iannaccone is an Ophthalmologist in Chapel Hill, North Carolina. Dr. Iannaccone is rated as a Distinguished provider by MediFind in the treatment of Retinal Vasculopathy with Cerebral Leukodystrophy. His top areas of expertise are Retinitis Pigmentosa, Retinopathy Pigmentary Mental Retardation, X-Linked Retinitis Pigmentosa (XLRP), and Usher Syndrome Type 2A. Dr. Iannaccone is currently accepting new patients.
State University Of Iowa
Ian Han is an Ophthalmologist in Iowa City, Iowa. Dr. Han has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Retinal Vasculopathy with Cerebral Leukodystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinitis Pigmentosa, Cataract Removal, and Vitrectomy. Dr. Han is currently accepting new patients.
Jules Stein Eye Institute Medical Group
Tara Mccannel is an Ophthalmologist in Arcadia, California. Dr. Mccannel is rated as an Experienced provider by MediFind in the treatment of Retinal Vasculopathy with Cerebral Leukodystrophy. Her top areas of expertise are Melanoma of the Eye, Uveal Melanoma, Metastatic Uveal Melanoma, Vitrectomy, and Cataract Removal.
Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center